Novartis received a score of 100 on the Corporate Equality Index from the Human Rights Campaign. Among other requirements, this means the company has a written policy pledging to vet vendors for LGBTQ policies (1)(2). Novartis’s Environmental Sustainability Criteria for Suppliers requires that each “Supplier shall ensure that all products and/or services procured by Novartis should be carbon neutral by 2030” (3).

Novartis will not match employee donations to churches or religious organizations (1).

Novartis does not provide viewpoint protections for its employees (1).

Novartis’s PGLE membership reflects its commitment to “operationalize” company coverage of transgender surgery and treatment, the vetting of business partners based on LGBTQ+ policies, and the financial support of LGBTQ organizations on a global level (1)(2)(3)(4). Novartis publishes “The Novartis in Society Integrated Report” to outline its ESG efforts” which includes its 2030 environmental sustainability strategy, the goal of Net Zero by 2040, and its signature on The Climate Pledge (5)(6)(7). Novartis joined the Business for Innovative Climate and Energy Policy (BICEP) that advocates for ESG to policymakers and is a member of the Business Coalition for the Equality Act (8)(9).

Novartis has a perfect score on the HRC’s 2022 Corporate Equality Index. This score indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2). Novartis made a statement that it is “carefully evaluating” how the overturning of Roe v. Wade may impact its associates and that it would make abortions accessible to its employees (3). Novartis is a founding member of the PGLE, a Silver sponsor of Out and Equal and a corporate partner of the National LGBT Chamber of Commerce (4)(5)(6).

Novartis has not used its PAC donations for ideological purposes and lobbies in a manner consistent with its business interests (1)(2)(3).